Mitochondrial Quality Control in Age-Related Diseases: From Molecular Architecture to Precision Therapeutics
Antioxidants · 30.06.2026 · 15 (7) · 830
DOI: 10.3390/antiox15070830 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 30.06.2026. Verfasst von Jingmin Che und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi Provincial Key Laboratory of Infection and Immune Diseases, Shaanxi Provincial People's Hospital, Xi'an 710068, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Basic Research Program of Shaanxi Province, Shannxi Province Key Research and Development Program General Project.
Abstract (Originalsprache)
Background: Mitochondria are the primary organelles that regulate cellular bioenergetic metabolism and maintain homeostasis, providing essential structural support for optimal cell survival. Nonetheless, advancing age leads to cumulative damage to mitochondrial structure and functional integrity, which is a defining characteristic of biological aging and is closely linked to the emergence and progression of numerous age-related diseases, including neurodegenerative disorders, cardiovascular diseases, and metabolic disorders. Scope of review: This article offers a thorough summary and review of mitochondrial quality control (MQC), emphasizing numerous critical processes, including mitochondrial biosynthesis, dynamic remodeling (fusion and fission), and mitophagy. We thoroughly elucidate the molecular pathways that regulate MQC and demonstrate how age-related dysregulation precipitates cellular senescence, highlighting the transition from physiological maintenance to pathological malfunction, which ultimately culminates in cellular aging. Conclusions and implications: This study systematically elaborates the pathophysiological mechanisms in the field, comprehensively evaluates the clinical translational potential of targeting the MQC pathway, highlights the key objectives of “restoring mitochondrial plasticity and removing dysfunctional mitochondria”, and explores novel intervention strategies. The restoration of normal mitochondrial function in cells throughout aging is a very promising path for precision medicine therapeutics with great translational potential, according to recent state-of-the-art research. The development of novel therapeutic approaches to improve functional healthy mitochondria can effectively delay aging and reduce the rising global burden of age-related diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shaanxi Provincial Key Laboratory of Infection and Immune Diseases, Shaanxi Provincial People's Hospital, Xi'an 710068, China.
- Shaanxi Engineering Research Center of Cell Immunology, Shaanxi Provincial People's Hospital, Xi'an 710068, China.
- Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China.
- Department of Oncology, Shaanxi Provincial People's Hospital, Xi'an 710068, China.
- College of Forensic Medicine, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
ORCID-Profile: Jingmin Che
Förderung
- National Natural Science Foundation of China
- Natural Science Basic Research Program of Shaanxi Province
- Shannxi Province Key Research and Development Program General Project
Zitieren
APA
Che, J., Sun, Y., Wang, F., Feng, Q., Xu, C., & Li, X. (2026). Mitochondrial Quality Control in Age-Related Diseases: From Molecular Architecture to Precision Therapeutics. Antioxidants, 15(7), 830. https://doi.org/10.3390/antiox15070830
Vancouver
Che J, Sun Y, Wang F, Feng Q, Xu C, Li X. Mitochondrial Quality Control in Age-Related Diseases: From Molecular Architecture to Precision Therapeutics. Antioxidants. 2026;15(7):830. doi:10.3390/antiox15070830
BibTeX
@article{Che2026,
author = {Che, Jingmin and Sun, Ye and Wang, Fang and Feng, Qing and Xu, Cuixiang and Li, Xuhui},
title = {Mitochondrial Quality Control in Age-Related Diseases: From Molecular Architecture to Precision Therapeutics},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {7},
pages = {830},
doi = {10.3390/antiox15070830}
}
EUVIMED